Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

 

Ampersand Capital Partners buys Purna Pharmaceuticals 

Ampersand Capital Partners, a life sciences and healthcare-focused private equity firm, has acquired Purna Pharmaceuticals, a Belgian contract development and manufacturing service provider (CDMO) for liquid and semi-solid medicines for pharmaceutical companies, from alternative investment fund manager Creafund.

CMA issues hold-separate orders on Welltower’s UK care home acquisitions

The UK Competition and Markets Authority (CMA) has ordered US healthcare REIT Welltower to pause the integration process for the 600+ UK care homes it bought in October 2025, as it considers whether controlling all three of the largest for-profit players in the market might raise competition concerns.

Australia’s Ramsay might sell French hospital subsidiary Santé stake to Predica instead of demerging

Ramsay Health Care, Australia’s biggest private hospital group by revenue, may drop plans to demerge its struggling European business, Ramsay Santé, and instead offload its majority stake to the other main shareholder. Ramsay appointed investment bank Goldman Sachs in early 2025 to review its options for Santé. Many had expected the group to spin off the European business via an in-species distribution of Sante shares to Ramsay Health Care shareholders. But sources quoted in the Australian press now suggest that option has been dropped. 

Juvisé Pharmaceuticals secures €550 refinancing from Hayfin Capital Management

Juvisé, a France-based speciality pharmaceutical company focusing on essential medicines, has secured €550 million in refinancing from investment firm Hayfin. The financing includes €400 million of existing debt and a new €150 million line for capital expenditure, focusing on future M&A opportunities.

Find Us